Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Stelco Holdings Inc (STLC.TO)

Stelco Holdings Inc (STLC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index Newswire.ca - Wed Oct 30, 4:15PM CDT

/CNW/ - Cleveland-Cliffs Inc (NYSE:CLF) and Stelco Holdings Inc. (TSX:STLC) have agreed to merge in a cash and stock combination. Each share of Stelco Holdings...

SPGI : 483.31 (+0.61%)
STLC.TO : 68.42 (+0.43%)
CLF : 13.27 (+2.23%)
Stocks in play: Stelco Holdings Inc. Baystreet - Wed Oct 30, 9:01AM CDT

Today announced that regulatory and program approvals under the Investment Canada Act and Strategic ...

STLC.TO : 68.42 (+0.43%)
Stocks in play: Stelco Holdings Inc. Baystreet - Wed Oct 9, 9:26AM CDT

Announced that the Canadian Competition Bureau has issued a “no-action letter”, confirming that the ...

STLC.TO : 68.42 (+0.43%)
Hamilton steel maker Stelco Holdings sold to Cleveland-Cliffs for $3.4 billion Canadian Press - Mon Jul 15, 8:57AM CDT

Hamilton, Ont.-based steel maker Stelco Holdings Inc. is set to be acquired by Cleveland-Cliffs Inc. for $3.4 billion.

STLC.TO : 68.42 (+0.43%)
Futures Rise to End Week Baystreet - Fri Sep 22, 2023

TSX futures rose on Friday, boosted by an uptick in prices of most commodities, but stocks were set ...

STLC.TO : 68.42 (+0.43%)
Stelco’s Q4 Net Income Falls 96% To $23 Million Baystreet - Fri Feb 24, 2023

Canadian steel producer Stelco Holdings (STLC) has reported disappointing fourth-quarter earnings that ...

STLC.TO : 68.42 (+0.43%)
Rolls of coiled coated steel are shown at Stelco in Hamilton on June 29, 2018. THE CANADIAN PRESS/Peter Power
Stelco reports earnings down 74% in Q3 due to lower steel prices, inflation Canadian Press - Tue Nov 15, 2022

HAMILTON — Stelco Holdings Inc. says its net earnings for the third quarter ended Sept. 30 were down by almost 74 per cent year-over-year to $158 million, or $2.33 per diluted share.

STLC.TO : 68.42 (+0.43%)
Most actively traded companies on the Toronto Stock Exchange Canadian Press - Thu Sep 22, 2022

Some of the most active companies traded Thursday on the Toronto Stock Exchange:

TRP.TO : 64.61 (-0.23%)
ABX.TO : 26.60 (-1.15%)
SU.TO : 52.46 (-0.19%)
CNQ.TO : 47.28 (-0.15%)
TD.TO : 76.76 (-0.27%)
CVE.TO : 21.89 (-2.23%)
STLC.TO : 68.42 (+0.43%)
H.TO : 44.72 (-0.25%)
Shadows of workers are reflected on rolls of coated steel at Stelco in Hamilton, Ont. in a Friday, June 29, 2018 file photo. THE CANADIAN PRESS/Peter Power
Stelco offers to buy back up to nearly half of its shares for $35 per share Canadian Press - Thu Sep 22, 2022

HAMILTON — Stelco Holdings Inc. is offering to buy back nearly half of its outstanding shares at a price of $35 per share.

STLC.TO : 68.42 (+0.43%)
Stelco Q2 Net Income Rises 53% To $554 Million Baystreet - Thu Aug 11, 2022

Stelco Holdings’ (STLC) second quarter net income increased 53% from a year earlier to $554 million ...

STLC.TO : 68.42 (+0.43%)

Barchart Exclusives

Thanks to Wall Street, Novo Nordisk Stock is Now a Buy Barchart - Sat Nov 2, 10:15AM CDT
Novo Nordisk has lost about a quarter of its value since the end of June. Meanwhile, indications are that its diabetes and weight-loss drugs may be useful in fighting cardiovascular disease, arthritis, opioid and alcohol addiction, and Alzheimer's. Novo remains a leader in the sector, and is trading at a valuation a third cheaper than competitor, Eli Lilly. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot